The Purpose Of Clinical Observatinon On The Prostatitis Appraise The Value Of Curse Effected With Qianliebao Ⅲ

Objective:The forefront of security through observation of clinical trial tablets in the treatment of chronic prostatitis to determine the forefront of drug safety security film.Method:Randomized manner with a diagnosis of chronic prostatitis clinic were randomly divided into two groups for the treatment group and control group, treatment group received the forefront of the protection given to the QIANLIEBAO Pills of the security chip analog control agent, the treatment cycle is 28 days, to confirm the diagnosis safety index given after inspection, evaluation of drug safety evaluation of drug efficacy at the same time. Clinical evaluation of leukocyte reduction in the number with prostatic fluid to evaluate the classification, the use of internationally harmonized system of NIH-CPSI score was evaluated criteria to evaluate the efficacy of traditional Chinese medicine symptom score, safety indicators used AST, ALT, BUN, Cr, ECG and other tests. Data were analyzed using statistical software Cdas2.0.Results:No difference in age, duration of the control groups (P> 0.05) the QIANLIEBAO Pills total effective rate was 86.1%, with clear differences between the control group (P<0.05), controlled before and after treatment showed no significant difference in safety, the results show the forefront of security safe and effective film.Conclusion:1 QIANLIEBAO pills in the treatment of chronic prostatitis ensure total effective rate was 86.1%;2 QIANLIEBAO pills can significantly change the clinical symptoms score;3 QIANLIEBAO pills can significantly change the number of white blood cells in prostatic fluid.